LINC01299

Across TCGA pan-cancer cohorts, LINC01299 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01299’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC01299 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01299 is over-expressed in tumor.

LUAD, STAD, and HNSC are the cancer types where LINC01299 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01299 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.026	.004	3	view →
STAD	Male	All	+0.014	.019	3	view →
HNSC	Female	IV	+0.016	.013	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC01299–LUAD

Open the LUAD breakdown →